Browse > Article

Evaluation of Serum Insulin-Like Growth Factor(IGF)-I, Insulin-Like Growth Factor Binding Protein(IGFBP)-2 and IGFBP-3 Levels in Healthy Korean Children  

Yang, Gi Hoon (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
Jung, Hye Lim (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
Kim, Deok Soo (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
Shim, Jae Won (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
Shim, Jung Yeon (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
Park, Moon Soo (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.48, no.3, 2005 , pp. 298-305 More about this Journal
Abstract
Purpose : We performed this study to evaluate the mean serum levels of insulin-like growth factor (IGF)-I, insulin-like growth factor binding protein(IGFBP)-2 and IGFBP-3 in healthy Korean children according to age and sex. Methods : Ninety two healthy children, consisting of 42 boys and 50 girls, were classified into five groups according to age : neonate; infancy; early childhood; late childhood; and adolescence. We measured serum levels of IGF-I, IGFBP-2 and IGFBP-3 by enzyme-linked immunosorbent assay(ELISA) and analysed the serum levels according to sex and age group. Results : For boys, the mean serum levels of IGF-I(ng/mL) in neonate, infancy, early childhood, late childhood and adolescence were $41.1{\pm}3.6$, $70.9{\pm}33.7$, $103.5{\pm}97.2$, $89.8{\pm}46.5$ and $51.4{\pm}27.8$, respectively. Those of IGFBP-2(ng/mL) were $8.2{\pm}3.4$, $5.8{\pm}0.4$, $9.3{\pm}4.0$, $9.5{\pm}1.1$ and $7.0{\pm}0.5$, respectively. Those of IGFBP-3(ng/mL) were $559.2{\pm}215.2$, $1,333.3{\pm}692.5$, $2,254.6{\pm}1,513.8$, $2,447.1{\pm}1,464.2$, $1,533.6{\pm}807.4$, respectively. For girls, the mean serum levels of IGF-I(ng/mL) according to five age groups were $53.3{\pm}9.5$, $99.3{\pm}45.8$, $69.6{\pm}51.1$, $106.2{\pm}67.0$ and $145.1{\pm}127.8$, respectively. Those of IGFBP-2 (ng/mL) were $9.1{\pm}7.4$, $5.3{\pm}0.9$, $6.9{\pm}2.0$, $10.5{\pm}3.0$ and $7.9{\pm}1.3$, respectively. Those of IGFBP-3(ng/mL) were $858.2{\pm}433.4$, $1,834.8{\pm}851.3$, $1,404.3{\pm}570.2$, $2,203.5{\pm}899.4$ and $2,029.3{\pm}1,316.7$, respectively. There were significant positive correlations observed between IGF-I and IGFBP-3 levels(r=0.589, P=0.000). Conclusion : IGF-I and IGFBP-3 levels increased as children get older. The peak level of IGFBP-3 was observed in late childhood for both boys and girls, suggesting a current trend of children reaching peak growth velocity before adolescence. The IGFBP-2 level was higher in neonates compare to infancy, suggesting that IGFBP-2 is an important substance for fetal growth.
Keywords
Insulin-like growth factor-1; Insulin-like growth factor binding protein-2; Insulin-like growth factor binding protein-3;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Cohick WS, Clemmons DR. The insulin-like growth factors. Annu Rev Physiol 1993;55:131-53   DOI   ScienceOn
2 Furlanetto RW, Cara JF. Somatomedin-C/insulin-like growth factor-I as a modulator of growth during childhood and adolescence. Horm Res 1986;24:177-84   DOI   PUBMED
3 Martin JL, Willetts KE, Baxter RC. Purification and properties of a novel insulin-like growth factor-II binding protein from transformed human fibroblasts. J Biol Chem 1990;265:4124-30
4 Kim HS, Nagalla SR, Oh Y, Wilson E, Roberts CT Jr, Rosenfeld RG. Identification of a family of low-affinity insulin-like growth factor binding proteins(IGFBPs) : characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci USA 1997;94:12981-6
5 Press M, Tamborlane WV, Sherwin RS. Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes. N Engl J Med 1984;310:810-5   DOI   ScienceOn
6 Bang P, Westgren M, Schwander J, Blum WF, Rosenfeld RG, Stangenberg M. Ontogeny of insulin-like growth factor-binding protein-1, -2, and -3 : quantitative measurements by radioimmunoassay in human fetal serum. Pediatr Res 1994;36:528-36   DOI   ScienceOn
7 Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, et al. Serum levels of insulin-like growth factor(IGF)-binding protein-3(IGFBP-3) in healthy infants, children, and adolescents : the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995;80:2534-42   DOI   ScienceOn
8 Gomez JM, Maravall FJ, Gomez N, Navarro MA, Casamitjana R, Soler J. The IGF-I system component concentrations that decrease with aging are lower in obesity in relationship to body mass index and body fat. Growth Horm IGF Res 2004;14:91-6.   DOI   ScienceOn
9 Hoybye C, Hilding A, Jacobsson H, Thoren M. Growth hormone treatment improves body composition in adults with Prader-Willi syndrome. Clin Endocrinol 2003;58:653-61   DOI   ScienceOn
10 Lofqvist C, Andersson E, Gelander L, Rosberg S, Blum WF, Albertsson-Wikland K. Reference values for IGF-I throughout childhood and adolescence : a model that accounts simultaneously for the effect of gender, age, and puberty. J Clin Endocrinol Metab 2001;86:5870-6   DOI   ScienceOn
11 Blum WF, Albertsson-Wikland K, Rosberg S, Ranke MB. Serum levels of insulin-like growth factor I(IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 1993;76:1610-6   DOI   ScienceOn
12 Amiel SA, Sherwin RS, Hintz RL, Gertner JM, Press CM, Tamborlane WV. Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetes. Diabetes 1984;33:1175-9   DOI   ScienceOn
13 Bennett A, Wilson DM, Liu F, Nagashima R, Rosenfeld RG, Hintz RL. Levels of insulin-like growth factors I and II in human cord blood. J Clin Endocrinol Metab 1983;57:609-12   DOI
14 Laron Z, Avitzur Y, Klinger B. Carbohydrate metabolism in primary growth hormone resistance(Laron syndrome) before and during insulin-like growth factor-I treatment. Metabolism 1995;44(10 Suppl 4):113S-8S   DOI   ScienceOn
15 Ali O, Cohen P, Lee KW. Epidemiology and biology of insulin-like growth factor binding protein-3(IGFBP-3) as an anti-cancer molecule. Horm Metab Res 2003;35:726-33   DOI   ScienceOn
16 Tapanainen P, Kaar ML, Leppaluoto J, Huttunen NP, Knip M. Normal stimulated growth hormone secretion but low peripheral levels of insulin-like growth factor I in prepubertal children with insulin-dependent diabetes mellitus. Acta Paediatr 1995;84:646-50   DOI   ScienceOn
17 Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 1989;10:68-91   DOI   ScienceOn
18 Gapstur SM, Gann PH, Kopp P, Colangelo LA, Longcope C, Liu K. Serum IGF-I and IGFBP-3 concentrations in young men : cross-sectional and longitudinal associations with age, BMI, waist circumference, physical activity and race. Proceedings of the American Association for Cancer Research; 2002 Apr 6-10; San Francisco. Philadelphia : American Association for Cancer Research, 2002
19 Koc E, Bideci A, Cinaz P, Unlu M, Atalay Y, Turkyilmaz C. Insulin-like growth factor(IGF)-I and IGF-binding protein-3 in relation to hemoglobin concentration in healthy term infants. J Pediatr Endocrinol Metab 1997;10:609-13
20 Wood TL, Streck RD, Pintar JE. Expression of the IGFBP-2 gene in post-implantation rat embryos. Development 1992;114:59-66
21 Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P. The human insulin-like growth factor(IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 1995;9:361-7   DOI   ScienceOn
22 Guler HP, Zapf J, Schmid C, Froesch ER. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol 1989;121:753-8
23 Oh J, Ramondetta LM, Fritsche HA, Bast RC, Mills GB, Wolf JK. Serum IGF-1, IGFBP-2, and IGFBP-3 in advanced ovarian cancer. Proceedings of the American Association for Cancer Research; 2002 Apr 6-10; San Francisco. Philadelphia : American Association for Cancer Research, 2002
24 Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor- binding protein(IGFBP) superfamily. Endocr Rev 1999;20:761-87   DOI   ScienceOn
25 Kim SH, Ku SY, Jee BC, Suh CS, Choi YM, Kim JG, et al. Clinical efficacy of serum insulin-like growth factor-I (IGF-I), IGF-II, and IGF binding protein-3(IGFBP-3) in predicting the prognosis of in vitro fertilization and embryo transfer. Korean J Obstet Gynecol 2003;46:802-9
26 Shin CH, Yang SW. Changes of insulin-like growth factor-I, insulin-like growth factor binding protein-3 and 24-hour urinary growth hormone in prepubertal children with insulin dependent diabetes mellitus. J Korean Diabet Assoc 1999;23:25-35
27 Bloch CA, Clemons P, Sperling MA. Puberty decreases insulin sensitivity. J Pediatr 1987;110:481-7   DOI   PUBMED
28 Gerich JE. Rationale for inhibition of growth hormone secretion in the management of the diabetic patient. Scand J Gastroenterol Suppl 1986;119:154-7
29 Barrios V, Buno M, Pozo J, Munoz MT, Argente J. Insulin-like growth factor-binding protein-2 levels in pediatric patients with growth hormone deficiency, eating disorders and acute lymphoblastic leukemia. Horm Res 2000;53:221-7   DOI   ScienceOn
30 Ehrlich RM. Diabetes mellitus in childhood. Pediatr Clin North Am 1974;21:871-84
31 Clayton KL, Holly JM, Carlsson LM, Jones J, Cheetham TD, Taylor AM, et al. Loss of the normal relationships between growth hormone, growth hormone-binding protein and insulin-like growth factor-I in adolescents with insulin-dependent diabetes mellitus. Clin Endocrinol 1994;41:517-24   DOI   ScienceOn
32 Brabant G, von zur Muhlen A, Wuster C, Ranke MB, Kratzsch J, Kiess W, et al. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system : results from a multicenter study. Horm Res 2003;60:53-60   DOI   ScienceOn
33 Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults : relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994;78:744-52   DOI   ScienceOn
34 Kim HS, Rosenfeld RG, Oh YM. Biological roles of insulin-like growth factor binding proteins(IGFBPs). Exp Mol Med 1997;29:85-96   DOI   ScienceOn
35 Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994;15:80-101
36 Lassarre C, Hardouin S, Daffos F, Forestier F, Frankenne F, Binoux M. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res 1991;29:219-25   DOI   ScienceOn
37 Kelley KM, Oh Y, Gargosky SE, Gucev Z, Matsumoto T, Hwa V, et al. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 1996;28:619-37   DOI   ScienceOn
38 Batch JA, Baxter RC, Werther G. Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. J Clin Endocrinol Metab 1991;73:964-8   DOI